Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

14.21 -0.01 (-0.04%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

24 25 Next >

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

July 19, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

7 ‘Death Cross’ Stocks That Could Be Contrarian Buys ↗

July 17, 2024

Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position.

Via InvestorPlace

Is Iovance Biotherapeutics a Millionaire Maker? ↗

July 14, 2024

This biotech's future is bright, but how good could it get for investors?

Via The Motley Fool

3 Under-$10 Biotech Stocks That Could Make You Rich ↗

July 11, 2024

Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis.

Via InvestorPlace

What's Going On With Iovance Biotherapeutics Today? ↗

May 24, 2024

On Thursday, Iovance revealed updated clinical findings for lifileucel in conjunction with pembrolizumab as a treatment for frontline advanced melanoma, as well as implementation data, to be presented...

Via Benzinga

Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking ↗

May 10, 2024

Via Benzinga

How Is The Market Feeling About Iovance Biotherapeutics? ↗

May 09, 2024

Via Benzinga

Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday ↗

July 11, 2024

Via Benzinga

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

June 28, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Is It Too Late to Buy Iovance Biotherapeutics Stock? ↗

June 28, 2024

The stock is down more than 50% from its 52-week high.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

June 21, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

3 Top Penny Stocks to Skyrocket Your Wealth in 2024 ↗

June 21, 2024

Find out about the top penny stocks to buy this year for a chance to see incredible results down the road as they soar to new heights.

Via InvestorPlace

The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why ↗

June 10, 2024

New data indicate that its cell therapy could soon find a larger market.

Via The Motley Fool

Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets

May 29, 2024

Oncotelic Therapeutics (OTC: OTLC) Inks Deal With Mosaic ImmunoEngineering To Sell Clinical-Stage Necroptosis Cancer Therapy Assets

Via News Direct

Iovance Biotherapeutics to Present at Upcoming Conferences and Events

May 24, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 24, 2024

Via Benzinga

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting

May 23, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗

May 22, 2024

These biotech stocks have just launched their first products.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

May 17, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

4 Small-Cap Value Stocks That Could Go Parabolic ↗

May 16, 2024

These four small-cap stocks scan as deeply undervalued right now.

Via The Motley Fool

The 3 Most Undervalued Biotech Stocks to Buy in May 2024 ↗

May 11, 2024

Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns.

Via InvestorPlace

Why Iovance Stock Is Down 18% Today ↗

May 10, 2024

Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 10, 2024

Via Benzinga

IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

IOVA stock results show that Iovance Biotherapeutics met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates

May 09, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

Got $500? These Hot Growth Stocks Are Screaming Buys Right Now ↗

May 05, 2024

The time to jump into a red-hot growth prospect is usually right now...before any more investors identify the opportunity.

Via The Motley Fool

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

May 01, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Present at Upcoming Conferences

April 30, 2024

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Where Will Iovance Biotherapeutics Stock Be in 5 Years? ↗

April 28, 2024

Is this rising healthcare stock a good buy right now?

Via The Motley Fool

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.